Cl-amidine confers organ protection and improves survival in hemorrhagic shock rats via the PAD4-CitH3-NETs axis
PLOS One · 2025
DOI: 10.1371/journal.pone.0327085 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Huiting Yun und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diagnosis and Treatment for Cadre, The Fourth Medical Center of PLA General Hospital, Beijing, China. Hauptthemen laut MEDLINE: Shock, Hemorrhagic, Extracellular Traps, Histones, Ornithine. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Major Project Fund of the Logistics Support Department of the Military Commission.
Abstract (Originalsprache)
Background
The occurrence of multi-organ dysfunction following hemorrhagic shock (HS) remains a critical clinical challenge. The excessive formation of neutrophil extracellular trap (NET) Has been identified as a pivotal pathogenic mechanism. This study preliminarily elucidated the protective mechanism of the PAD4 inhibitor Cl-amidine in a rat model of HS.
Methods
Male Sprague-Dawley rats were subjected to sublethal (40% blood loss, n = 8) or lethal (50% blood loss, n = 10) HS. Rats were divided into Sham group (catheter placement only), HS group (catheter placement followed by blood withdrawal), Vehicle group (0.9% saline), and Cl-amidine (10 mg/kg in 0.9% saline) groups.
Results
Cl-amidine significantly improved the 72-h survival rate and delayed mortality in lethal HS. In Sublethal HS, the drug corrected metabolic disturbances, such as reduced lactate accumulation, while maintaining mean arterial pressure. Mechanistically, the effects of Cl-amidine included reducing circulating cell-free DNA (cf-DNA) and tissue citrullinated histone H3 (CitH3) levels, suppressing PAD4 expression, and improving histopathological outcomes (reduced edema and restored intestinal barrier integrity by upregulation of tight junction proteins Claudin-1/ZO-1). Moreover, Cl-amidine inhibited neutrophil infiltration through ICAM-1 downregulation and reduced the production of TNF-α and IL-6.
Conclusions
In conclusion, Cl-amidine protects against HS by targeting the PAD4-CitH3-NETs axis, breaking the vicious cycle of “NETs-inflammation”, restoring barrier integrity, and alleviating multi-organ damage. The synergistic downregulation of ICAM-1 further enhances the therapeutic efficacy, highlighting Cl-amidine as a novel NETs-modulating strategy for HS. This study provides a theoretical and therapeutic foundation for the prevention and treatment of multi-organ injury following HS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Diagnosis and Treatment for Cadre, The Fourth Medical Center of PLA General Hospital, Beijing, China.
- Hebei North University, Hebei Province, China.
- Department of Burns and Plastic Surgery, The Fourth Medical Center of PLA General Hospital, Beijing, China.
- Research Center of Plastic Surgery Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
ORCID-Profile: Hongjie Duan
Förderung
- The Major Project Fund of the Logistics Support Department of the Military Commission
Zitieren
APA
Yun, H., Chi, Y., Wei, B., Bai, H., Cao, W., Zhang, Z., Zhang, Y., Zhang, Q., & Duan, H. (2025). Cl-amidine confers organ protection and improves survival in hemorrhagic shock rats via the PAD4-CitH3-NETs axis. PLOS One. https://doi.org/10.1371/journal.pone.0327085
Vancouver
Yun H, Chi Y, Wei B, Bai H, Cao W, Zhang Z, et al. Cl-amidine confers organ protection and improves survival in hemorrhagic shock rats via the PAD4-CitH3-NETs axis. PLOS One. 2025. doi:10.1371/journal.pone.0327085
BibTeX
@article{Yun2025,
author = {Yun, Huiting and Chi, Yunfei and Wei, Bin and Bai, Hailiang and Cao, Weihua and Zhang, Zheng and Zhang, Yufang and Zhang, Quanxi and Duan, Hongjie},
title = {Cl-amidine confers organ protection and improves survival in hemorrhagic shock rats via the PAD4-CitH3-NETs axis},
journal = {PLOS One},
year = {2025},
doi = {10.1371/journal.pone.0327085}
}
EUVIMED